Ask Warren

HLB Pharmaceutical

047920 · KOSDAQ · ₩047920 · HLB제약

₩9,950▲ ₩60 (0.61%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • 5%+ holding report주식등의대량보유상황보고서(일반)

    Predicted impact: Low

    Oct 21, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최

    Predicted impact: Low· Actual: −16.5% vs sector, volume 0.5× normal (5 trading days)

    Oct 12, 2026Open on DART
  • New Facility Investment, etc.신규시설투자등Oct 1, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 28, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 28, 2026Open on DART
  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Sep 18, 2026Open on DART
  • Securities Issuance Results Report증권발행실적보고서Sep 18, 2026Open on DART
  • Subscription Results of Rights Offering or Stock-Related Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의청약결과(자율공시)Sep 17, 2026Open on DART
  • [Amended] Subscription Results of Rights Offering or Stock-Related Bonds, etc. (Voluntary Disclosure)[기재정정]유상증자또는주식관련사채등의청약결과(자율공시)Sep 15, 2026Open on DART
  • Subscription Results of Rights Offering or Stock-Related Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의청약결과(자율공시)Sep 14, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 9, 2026Open on DART
  • Final Determination of Issue Price for Rights Offering유상증자최종발행가액확정Sep 8, 2026Open on DART
  • Amended: Prospectus[기재정정]투자설명서Sep 8, 2026Open on DART
  • Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Sep 8, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Sep 8, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 3, 2026Open on DART
  • Amended: Prospectus[기재정정]투자설명서Sep 1, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Aug 31, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 31, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 27, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 26, 2026Open on DART
  • Amended attachment: Securities registration statement[첨부정정]증권신고서(지분증권)Aug 14, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Aug 14, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 13, 2026Open on DART
  • Ex-Rights Date (Rights Offering)권리락 (유상증자)Aug 3, 2026Open on DART
  • [Amended] Determination of Issue Price for 1st Rights Offering[기재정정]유상증자1차발행가액결정Aug 3, 2026Open on DART
  • Determination of Issue Price for First Tranche of Rights Offering유상증자1차발행가액결정Aug 3, 2026Open on DART
  • Amended: Prospectus[기재정정]투자설명서Aug 3, 2026Open on DART
  • Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Aug 3, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Aug 3, 2026Open on DART
  • Amended: Prospectus[기재정정]투자설명서Jul 31, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Jul 31, 2026Open on DART
  • Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Jul 24, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jul 22, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jul 16, 2026Open on DART
  • Prospectus투자설명서Jul 3, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Jul 2, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Jun 18, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jun 18, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 4, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고May 22, 2026Open on DART
  • Securities registration statement증권신고서(지분증권)May 13, 2026Open on DART
  • Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)May 13, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 13, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Apr 23, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Apr 21, 2026Open on DART
  • [Amended Filing] Notice on Appointment, Dismissal or Mid-Term Departure of Independent Director[기재정정]독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: HLB Pharmaceutical / HLB제약 / 047920 / KRX:047920

Source: KRX statistical information